Price $80.25 |
Market Cap
203.9B
|
Sector Health Care |
Div. Growth
10.90%
|
|
P/E
18.0
|
P/B
7.09
|
P/S
4.37
|
Dividend %
3.20%
|
|
P/CF
-
|
P/FCF
321.9
|
Op. Cash Flow
11.04M
|
FCF
0.2
|
|
Op. Margin
26.90%
|
Net Margin
24.30%
|
ROE
42.30%
|
ROI
19.20%
|
|
ROA
13.20%
|
EPS Growth
26.10%
|
Current Ratio
1.2
|
Debt/Equity
87.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Community Health Systems Inc (CYH) | $10.92 | - | - | 884M | Strong Buy |
| Harrow Health Inc (HROW) | $8.71 | - | - | 159.6M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $4.62 | - | - | 166.4M | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.75 | - | - | 19.8M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.78 | - | - | 50.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
